{
  "bundle_id": "PBAC-PEPTIDE-GIP-GIPR-ED2-FULL-BUNDLE-001",
  "catalog_id": "PBAC-PEPTIDE-GIP-GIPR-ED2-FULL",
  "config_hash_sha256": "711155f695f7669c701a626e1bd872f9ab26d0906120a836ff48219145f75f32",
  "config_path": "configs/peptide_production/gip_gipr_ed2_full.json",
  "enablement_packet_id": "PBAC-ENAB-GIP-GIPR-LINEAR-SIMPLE-FORM-V1",
  "enablement_packet_schema_version": "pbac_enablement_packet_v1",
  "enablement_scope": "gip_gipr_canonical_l_linear_full_ed2_simple_termini_common_salts",
  "generated_at_utc": "2026-06-21T20:22:57Z",
  "noncanonical_or_complex_form_requires_specific_packet": true,
  "operational_protocol_excluded": true,
  "reference_ids": [
    "UNIPROT_P09681_GIP_HUMAN",
    "GTOPDB_TARGET_GIPR",
    "PUBMED_4307033_MERRIFIELD_SOLID_PHASE_PEPTIDE_SYNTHESIS",
    "PUBMED_2191922_FIELDS_NOBLE_FMOC_SPPS"
  ],
  "release_id": "PBAC-PEPTIDE-GIP-GIPR-ED2-FULL-V1",
  "source_reference_catalog_path": "source_reference_catalog.json",
  "synthesis_statement": "Class-specific non-operational enablement context: this packet identifies exact canonical L linear peptide molecules derived from the curated human gastric inhibitory polypeptide parent scaffold and simple terminal or common salt forms. It is not a synthesis protocol, formulation recipe, manufacturing instruction, dosing instruction, assay protocol, safety claim, efficacy claim, target-engagement claim, or therapeutic-use claim."
}
